
|Videos|March 31, 2021
Dr. Leonard Gomella on unanswered questions with biomarkers in prostate cancer
Author(s)Urology Times staff
Advertisement
Leonard G. Gomella, MD, chairman of the Department of Urology at the Sidney Kimmel Cancer Center, discusses questions that still need to be resolved with biomarkers for the diagnosis and management of patients with prostate cancer.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves Titan Prime Inflatable Penile Prosthesis
2
Phase 1 AcTION trial establishes RP2D for 225Ac-PSMA-617
3
FDA approves cefepime and zidebactam for complicated UTI
4
FDA updates in urology: May 2026
5











